Randomised clinical trial of a laxative alone versus a laxative and a bulking agent after primary repair of obstetric anal sphincter injury

BJOG. 2007 Jun;114(6):736-40. doi: 10.1111/j.1471-0528.2007.01331.x.

Abstract

Objective: To compare two postpartum laxative regimens in women who have undergone primary repair of obstetric anal sphincter injury.

Design: Randomised controlled trial.

Setting: National Maternity Hospital, Dublin.

Population: A total of 147 postpartum women who had sustained anal sphincter injury at vaginal birth.

Methods: Women were randomised to receive either lactulose alone thrice daily for the first three postpartum days followed by sufficient lactulose to maintain a soft stool over the following 10 days (lactulose group, n = 77) or the lactulose regimen combined with a sachet of ispaghula husk daily for the first 10 postpartum days (Fybogel group, n = 70). All patients kept a diary of bowel habit for the first 10 postpartum days and were invited to return for review at 3 months postpartum.

Main outcome measures: Patient discomfort with first postpartum bowel motion, incidence of postnatal constipation and incontinence and incontinence score in postnatal period.

Results: Pain scores were similar in the two treatment groups; but incontinence in the immediate postnatal period was more frequent with the two preparations compared with lactulose alone (32.86% versus 18.18%, P = 0.03).

Conclusions: This study does not support routine prescribing of a stool-bulking agent in addition to a laxative in the immediate postnatal period for women who have sustained anal sphincter injury at vaginal delivery.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anal Canal / injuries*
  • Anal Canal / surgery
  • Cathartics / therapeutic use*
  • Citric Acid / therapeutic use*
  • Constipation / drug therapy
  • Drug Combinations
  • Drug Therapy, Combination
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Lactulose / therapeutic use*
  • Obstetric Labor Complications / surgery*
  • Plant Extracts / therapeutic use*
  • Pregnancy
  • Puerperal Disorders / prevention & control
  • Sodium Bicarbonate / therapeutic use*
  • Treatment Outcome

Substances

  • Cathartics
  • Drug Combinations
  • Gastrointestinal Agents
  • Plant Extracts
  • Citric Acid
  • Lactulose
  • citric acid, ispaghula husk, sodium bicarbonate drug combination
  • Sodium Bicarbonate